Age-specific incidence of A/H1N1 2009 influenza infection in England from sequential antibody prevalence data using likelihood-based estimation.

Estimating the age-specific incidence of an emerging pathogen is essential for understanding its severity and transmission dynamics. This paper describes a statistical method that uses likelihoods to estimate incidence from sequential serological data. The method requires information on seroconversi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Marc Baguelin, Katja Hoschler, Elaine Stanford, Pauline Waight, Pia Hardelid, Nick Andrews, Elizabeth Miller
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2011
Materias:
R
Q
Acceso en línea:https://doaj.org/article/76a486a3d210420da0b294ca76a5766c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:76a486a3d210420da0b294ca76a5766c
record_format dspace
spelling oai:doaj.org-article:76a486a3d210420da0b294ca76a5766c2021-11-18T06:58:23ZAge-specific incidence of A/H1N1 2009 influenza infection in England from sequential antibody prevalence data using likelihood-based estimation.1932-620310.1371/journal.pone.0017074https://doaj.org/article/76a486a3d210420da0b294ca76a5766c2011-02-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21373639/?tool=EBIhttps://doaj.org/toc/1932-6203Estimating the age-specific incidence of an emerging pathogen is essential for understanding its severity and transmission dynamics. This paper describes a statistical method that uses likelihoods to estimate incidence from sequential serological data. The method requires information on seroconversion intervals and allows integration of information on the temporal distribution of cases from clinical surveillance. Among a family of candidate incidences, a likelihood function is derived by reconstructing the change in seroprevalence from seroconversion following infection and comparing it with the observed sequence of positivity among the samples. This method is applied to derive the cumulative and weekly incidence of A/H1N1 pandemic influenza in England during the second wave using sera taken between September 2009 and February 2010 in four age groups (1-4, 5-14, 15-24, 25-44 years). The highest cumulative incidence was in 5-14 year olds (59%, 95% credible interval (CI): 52%, 68%) followed by 1-4 year olds (49%, 95% CI: 38%, 61%), rates 20 and 40 times higher respectively than estimated from clinical surveillance. The method provides a more accurate and continuous measure of incidence than achieved by comparing prevalence in samples grouped by time period.Marc BaguelinKatja HoschlerElaine StanfordPauline WaightPia HardelidNick AndrewsElizabeth MillerPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 6, Iss 2, p e17074 (2011)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Marc Baguelin
Katja Hoschler
Elaine Stanford
Pauline Waight
Pia Hardelid
Nick Andrews
Elizabeth Miller
Age-specific incidence of A/H1N1 2009 influenza infection in England from sequential antibody prevalence data using likelihood-based estimation.
description Estimating the age-specific incidence of an emerging pathogen is essential for understanding its severity and transmission dynamics. This paper describes a statistical method that uses likelihoods to estimate incidence from sequential serological data. The method requires information on seroconversion intervals and allows integration of information on the temporal distribution of cases from clinical surveillance. Among a family of candidate incidences, a likelihood function is derived by reconstructing the change in seroprevalence from seroconversion following infection and comparing it with the observed sequence of positivity among the samples. This method is applied to derive the cumulative and weekly incidence of A/H1N1 pandemic influenza in England during the second wave using sera taken between September 2009 and February 2010 in four age groups (1-4, 5-14, 15-24, 25-44 years). The highest cumulative incidence was in 5-14 year olds (59%, 95% credible interval (CI): 52%, 68%) followed by 1-4 year olds (49%, 95% CI: 38%, 61%), rates 20 and 40 times higher respectively than estimated from clinical surveillance. The method provides a more accurate and continuous measure of incidence than achieved by comparing prevalence in samples grouped by time period.
format article
author Marc Baguelin
Katja Hoschler
Elaine Stanford
Pauline Waight
Pia Hardelid
Nick Andrews
Elizabeth Miller
author_facet Marc Baguelin
Katja Hoschler
Elaine Stanford
Pauline Waight
Pia Hardelid
Nick Andrews
Elizabeth Miller
author_sort Marc Baguelin
title Age-specific incidence of A/H1N1 2009 influenza infection in England from sequential antibody prevalence data using likelihood-based estimation.
title_short Age-specific incidence of A/H1N1 2009 influenza infection in England from sequential antibody prevalence data using likelihood-based estimation.
title_full Age-specific incidence of A/H1N1 2009 influenza infection in England from sequential antibody prevalence data using likelihood-based estimation.
title_fullStr Age-specific incidence of A/H1N1 2009 influenza infection in England from sequential antibody prevalence data using likelihood-based estimation.
title_full_unstemmed Age-specific incidence of A/H1N1 2009 influenza infection in England from sequential antibody prevalence data using likelihood-based estimation.
title_sort age-specific incidence of a/h1n1 2009 influenza infection in england from sequential antibody prevalence data using likelihood-based estimation.
publisher Public Library of Science (PLoS)
publishDate 2011
url https://doaj.org/article/76a486a3d210420da0b294ca76a5766c
work_keys_str_mv AT marcbaguelin agespecificincidenceofah1n12009influenzainfectioninenglandfromsequentialantibodyprevalencedatausinglikelihoodbasedestimation
AT katjahoschler agespecificincidenceofah1n12009influenzainfectioninenglandfromsequentialantibodyprevalencedatausinglikelihoodbasedestimation
AT elainestanford agespecificincidenceofah1n12009influenzainfectioninenglandfromsequentialantibodyprevalencedatausinglikelihoodbasedestimation
AT paulinewaight agespecificincidenceofah1n12009influenzainfectioninenglandfromsequentialantibodyprevalencedatausinglikelihoodbasedestimation
AT piahardelid agespecificincidenceofah1n12009influenzainfectioninenglandfromsequentialantibodyprevalencedatausinglikelihoodbasedestimation
AT nickandrews agespecificincidenceofah1n12009influenzainfectioninenglandfromsequentialantibodyprevalencedatausinglikelihoodbasedestimation
AT elizabethmiller agespecificincidenceofah1n12009influenzainfectioninenglandfromsequentialantibodyprevalencedatausinglikelihoodbasedestimation
_version_ 1718424110688632832